Misleading COVID-19 headlines from mainstream sources did more harm on Facebook than fake news
Misleading COVID-19 headlines from mainstream sources did more harm on Facebook than fake news
May 30, 2024 15:01 ET | MIT Sloan School of Management
Cambridge, MA, May 30, 2024 (GLOBE NEWSWIRE) -- Since the rollout of the COVID-19 vaccine in 2021, fake news on social media has been widely blamed for low vaccine uptake in the United States — but...
Catalyst Pharmaceutical logo
Catalyst Pharmaceuticals Receives U.S. FDA Approval For Increased Maximum Daily Dose For FIRDAPSE®
May 30, 2024 13:41 ET | Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., May 30, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing,...
Logo.jpg
Scilex Holding Company Sends Letters to the U.S. Securities and Exchange Commission and Financial Industry Regulatory Authority Regarding Illegal Market Manipulation of the Common Stock of Scilex Holding Company
May 30, 2024 13:19 ET | Scilex Holding Company
PALO ALTO, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and...
__USE THIS ONE - Inventures 2024 Masthead_Cropped__.jpg
Humanizing Technology to Speed Health Innovation in Alberta
May 30, 2024 13:00 ET | Alberta Innovates
$4.25 Million IDEATE Project Ignites Health Tech Innovation in Alberta
Statement from Dr. J
Statement from Dr. James Weber, CEO of GI Alliance, on the Passing of Basketball Legend Bill Walton
May 30, 2024 10:17 ET | GI Alliance
Dallas, TX, May 30, 2024 (GLOBE NEWSWIRE) -- It is with deep sorrow that we at GI Alliance acknowledge the passing of basketball legend Bill Walton. Bill was not only an extraordinary athlete, known...
Dr. Phillip Oberg
Dr. Phillip Oberg Joins Utah Gastro in St. George
May 30, 2024 09:40 ET | GI Alliance
St. George, UT, May 30, 2024 (GLOBE NEWSWIRE) -- Utah Gastroenterology welcomes the addition of Dr. Phillip Oberg, a board certified professional who treats all gastrointestinal diseases, while...
RECELL GO by AVITA Medical
AVITA Medical Announces FDA Approval of RECELL GO
May 30, 2024 09:15 ET | AVITA Medical
AVITA Medical receives FDA approval for RECELL GO, its next-generation device used to treat thermal burn wounds and full thickness skin defects.
Biognosys Spectronaut®  DIA Proteomics Analysis Software
Biognosys Launches Spectronaut 19 and Presents Advances with Its Research Platforms at the ASMS 2024 Annual Conference
May 30, 2024 09:15 ET | Biognosys AG
Biognosys launches Spectronaut 19 with significant performance improvements and presents advances with its research platforms at ASMS 2024
Verana+logo+horizontal.jpg
Verana Health Announces Launch of Qdata® Uveitic Macular Edema Module
May 30, 2024 09:00 ET | Verana Health, Inc.
Expansive, high-quality real-world dataset of more than 152,000 de-identified patients utilizes electronic health record data to confirm the diagnosis and better understand the outcomes of patients...
VIVUS Wordmark Blue 400x130@2X-RGB.png
Clinical Data Published at ASCO Support the Potential of VIVUS’ PANCREAZE® to Stabilize Weight and Improve Gastrointestinal Outputs in Patients with Pancreatic Cancer
May 30, 2024 09:00 ET | VIVUS LLC
CAMPBELL, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing...